Table 3.
Clinical diagnosis and seroprevalence of T. gondii in children with lymphoma in eastern China
| Clinical diagnosis | No. tested | No. positive | % | OR (95% CI) | P |
|---|---|---|---|---|---|
| Hodgkin's lymphoma | 172 | 32 | 18.6 | 2.1 (1.2–3.6) | 0.006 |
| NK/T-cell lymphoma | 13 | 5 | 38.5 | 5.7 (1.8–18.8) | 0.001 |
| Marginal zone B-lymphoma | 43 | 11 | 25.6 | 3.1 (1.4–6.8) | 0.003 |
| Mantle cell lymphoma | 12 | 1 | 8.3 | 0.8 (0.1–6.6) | 0.670 |
| Diffuse large B-cell lymphoma | 19 | 4 | 21.1 | 2.4 (0.8–7.8) | 0.126 |
| T-cell lymphoma | 17 | 1 | 5.9 | 0.6 (0.1–4.5) | 0.496 |
| Follicular lymphoma | 19 | 3 | 158 | 1.7 (0.5–6.2) | 0.304 |
| B-small lymphotic lymphoma | 13 | 4 | 30.8 | 4.1 (1.2–13.9) | 0.039 |
| Other | 6 | 1 | 16.7 | 1.8 (0.2–16.1) | 0.470 |
As compared with 9.9% seroprevalence of T. gondii antibodies in controls (31/314).